Importance of Achieving Complete Remission (CR) after Intensive Therapy for Acute Myeloid Leukemia (AML) in Older Adults Age ≥60 Years: Analysis of Risk Factors for Early Mortality and Re-Induction, and Impact of Quality of Response on Overall Survival (OS) in the ECOG-ACRIN E2906 Randomized Trial
Year: 2016
Type: article
Source: Blood
Authors: James M. Foran, Zhuoxin Sun, David F. Claxton, Hillard M. Lazarus, Mary L. Thomas, Ari Melnick, Ross L. Levine, Elisabeth Paietta, Daniel A. Arber, Yanming Zhang, Jacob M. Rowe, John E. Godwin, Jessica K Altman, Selina Luger, Aref Al-Kali, Hong Zheng, Keith W. Pratz, E. Randolph Broun, Bayard L Powell, Kristen O'Dwyer, Mark Litzow, Martin S. Tallman
Institutions: Mayo Clinic in Florida, Dana-Farber Cancer Institute, Penn State Cancer Institute, Penn State Milton S. Hershey Medical Center, University Hospitals of Cleveland, University Hospitals Cleveland Medical Center, VA Palo Alto Health Care System, Weill Cornell Medicine, Memorial Sloan Kettering Cancer Center, Montefiore Medical Center, Montefiore Einstein Comprehensive Cancer Center, Stanford University, Northwestern University, Shaare Zedek Medical Center, Bikur Cholim Hospital, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Abramson Cancer Center, University of Pennsylvania, Mayo Clinic, Pennsylvania State University, Johns Hopkins University, Johns Hopkins Medicine, Jewish Hospital, Atrium Health Wake Forest Baptist, Wake Forest Baptist Comprehensive Cancer Center, University of Rochester Medicine, University of Rochester
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2597243126